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background: Echocardiographic-guided left ventricular (LV) lead placement improves survival free from heart failure (HF) hospitalization in 
cardiac resynchronization therapy (CRT) recipients. This strategy may similarly reduce appropriate therapies for ventricular arrhythmias (VA).
methods: We analyzed 183 patients receiving CRT-defibrillators (CRT-D) prospectively randomized to echo-guided (n=108) or routine LV lead 
placement (n=75) in the STARTER trial. Echo-guided LV leads were targeted to the site of latest mechanical activation identified via radial strain 
dyssynchrony analysis. The primary endpoints were death or any appropriate CRT-D therapy for VA. Resynchronization was defined as a 50% reduction 
in time from peak anteroseptal to posterior wall strain at 6 month follow-up.
results: Over 3.7±2.1 years, 62 (33%) patients died and 40 (22%) received appropriate CRT-D therapy. Compared to routine patients, echo-
guided patients had improved CRT-D therapy-free survival (HR = 0.64, 95% CI = 0.42-0.98, p=0.038). Patients randomized to echo-guided LV lead 
placement were more likely to resynchronize their LV (72% vs. 48%, p=0.006), and patients with LV resynchronization demonstrated improved 
therapy-free survival (HR = 0.49, 95% CI = 0.28-0.86, p=0.012).
conclusion: Echo-guided LV lead placement reduces the risk of death or appropriate CRT-D therapies compared to routine implant. Mechanical LV 
resynchronization appears to underlie this finding.
